Akeso Inc Sustainability Reports
Akeso, Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of innovative antibody drugs. The company mainly develops therapeutic bispecific and multispecific antibodies for oncology, immunology, and metabolic diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 254900ECWYGR3QW5GF30
FIGI: BBG00T5THCR3
12 reports from 2020 to 2025
